Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Garber

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Current Atherosclerosis Reports|August 19, 2008
HDL therapy for cardiovascular diseases: the road to HDL mimeticsC Roger White, Geeta Datta, Zhenghao Zhang, et al.
Neurobiology of Disease|April 7, 2009
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's diseaseShaila P Handattu, David W Garber, Candyce E Monroe, et al.
Atherosclerosis|October 30, 2010
Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effectsGaurav Nayyar, Shaila P Handattu, Candyce E Monroe, et al.
Vascular Disease Prevention|January 20, 2010
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.)C Roger White, Geeta Datta, Paulina Mochon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2005
Apolipoprotein A-I mimetic peptidesMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Circulation|August 28, 2002
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptideBrian J Van Lenten, Alan C Wagner, G M Anantharamaiah, et al.
Journal of Lipid Research|March 2, 2012
Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptidesGaurav Nayyar, Vinod K Mishra, Shaila P Handattu, et al.
Redox Biology|September 12, 2013
Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouseElena Ulasova, Jessica Perez, Bradford G Hill, et al.
Journal of Lipid Research|June 16, 2007
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptidesG M Anantharamaiah, Vinod K Mishra, David W Garber, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosisMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Current Atherosclerosis Reports|August 19, 2008
HDL therapy for cardiovascular diseases: the road to HDL mimeticsC Roger White, Geeta Datta, Zhenghao Zhang, et al.
Neurobiology of Disease|April 7, 2009
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's diseaseShaila P Handattu, David W Garber, Candyce E Monroe, et al.
Atherosclerosis|October 30, 2010
Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effectsGaurav Nayyar, Shaila P Handattu, Candyce E Monroe, et al.
Vascular Disease Prevention|January 20, 2010
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.)C Roger White, Geeta Datta, Paulina Mochon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2005
Apolipoprotein A-I mimetic peptidesMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Circulation|August 28, 2002
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptideBrian J Van Lenten, Alan C Wagner, G M Anantharamaiah, et al.
Journal of Lipid Research|March 2, 2012
Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptidesGaurav Nayyar, Vinod K Mishra, Shaila P Handattu, et al.
Redox Biology|September 12, 2013
Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouseElena Ulasova, Jessica Perez, Bradford G Hill, et al.
Journal of Lipid Research|June 16, 2007
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptidesG M Anantharamaiah, Vinod K Mishra, David W Garber, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosisMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Pageof 4